Metabolic Research
T-30
Dual GIP and GLP-1 receptor agonist widely referenced in metabolic and body-composition research.
- Classification
- Synthetic dual incretin receptor agonist peptide
- Supplied form
- Lyophilized powder, research vial
- Storage
- Lyophilized powder is typically stored refrigerated or frozen and protected from light. Prepared solutions are generally kept refrigerated and handled under standard laboratory practice.
- Solubility
- Water soluble; laboratory solutions are prepared with bacteriostatic or sterile water.
What T-30 is
T-30 (Tirzepatide) is a single peptide chain engineered to activate both the GIP and GLP-1 receptors. The dual-receptor mechanism is the defining feature discussed throughout the incretin literature.
Research context
Study endpoints reported in the literature include glucose regulation, appetite signalling, and changes in body composition. It is frequently used as a comparator in research examining newer multi-receptor agonists.
Handling in the laboratory
Supplied lyophilized in a 30mg research vial. Working concentration depends entirely on the solvent volume selected by the researcher.
Research disclaimer
Supplied for legitimate laboratory research purposes only. Not for human or veterinary use. Lucent Life does not provide medical advice, diagnosis, treatment, or dosing instructions.
Catalog listings
Frequently asked
How does T-30 differ from the R-Series?
T-30 targets two receptors (GIP and GLP-1); the R-Series adds glucagon receptor activity as a third target.
More reference pages
Research disclaimer: This page is a laboratory reference summary of published research context. Products supplied by Lucent Life are reference materials for in-vitro laboratory research only — not drugs, supplements, or products for human consumption.